The present invention provides compounds, compositions and methods for the inhibition
or treatment of conditions or disorders modulated by the STAT transcription factors,
particularly STAT4 and STAT6. Additionally, the compounds are useful for the diagnosis
of conditions dependent on STAT signaling.
